Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
512.84
+3.72 (0.73%)
Nov 20, 2024, 4:00 PM EST - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.60B in the quarter ending September 28, 2024, with 0.23% growth. This brings the company's revenue in the last twelve months to $42.37B, down -2.42% year-over-year. In the year 2023, Thermo Fisher had annual revenue of $42.86B, down -4.58%.
Revenue (ttm)
$42.37B
Revenue Growth
-2.42%
P/S Ratio
4.64
Revenue / Employee
$347,295
Employees
122,000
Market Cap
196.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck & Co. | 63.17B |
Pfizer | 59.38B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Abbott Laboratories | 41.22B |
Amgen | 32.53B |
Danaher | 23.74B |
TMO News
- 1 day ago - Thermo Fisher Scientific Inc. (TMO) Wolfe 2024 Healthcare Conference (Transcript) - Seeking Alpha
- 5 days ago - Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - Business Wire
- 7 days ago - Thermo Fisher Scientific: Near The Bottom And Attractively Valued - Seeking Alpha
- 9 days ago - Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024 - Business Wire
- 13 days ago - Thermo Fisher Scientific Declares Quarterly Dividend - Business Wire
- 4 weeks ago - Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy' - Seeking Alpha
- 4 weeks ago - Thermo Fisher raises profit forecast on strong demand for its tools and services - Reuters